January 16, 2023
Getting to the Heart of Chemotherapeutic Cardiotoxicity
January 16, 2023 — On any given Tuesday, you will find Brian C. Jensen, MD, cardiologist and physician-scientist,…
Read More
Patients seen at transplant centers had almost 80% higher odds to receive “bridge-to-transplant” designation
January 13, 2023
Medicare Policy Change Could Increase Inequity in Heart Transplant Access, Study Finds
January 13, 2023 — A change to Medicare policy surrounding heart transplant may lead to increased inequities in access…
Read More
ASNC releases comprehensive tool for assessing quality, setting meaningful goals, improving patient care in SPECT MPI laboratories
January 13, 2023
New Guide Will Change How Cardiac Imagers Approach Quality Improvement
January 13, 2023 — Nuclear stress testing performed with single-photon emission computed tomography (SPECT) is the most…
Read More
Medical center signs agreement to acquire the Company’s digital signal processing technology for arrhythmia care
January 13, 2023
BioSig Executes Agreement with Bellin Health for the Acquisition of its PURE EP Technology
January 13, 2023 — BioSig Technologies, Inc., an advanced digital signal processing technology company delivering…
Read More
ADVANCE Trial compares sac regression in the Medtronic Endurant II/IIs stent graft system and the Gore® Excluder AAA Device Family systems
January 12, 2023
Medtronic Announces First Enrollment in Head-to-head Global Randomized Trial Evaluating Durability of Endovascular Aneurysm Repair
January 12, 2023 — Medtronic announced the first patient enrollment in the ADVANCE Trial, a head-to-head randomized…
Read More
SELUTION SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA Investigational Device Exemption (IDE) approval to initiate its pivotal clinical trial for the treatment of coronary de novo lesions.
January 12, 2023
MedAlliance Selution SLR is the First DEB to Receive Coronary de novo IDE Approval, its Fourth FDA IDE DEB Approval
January 12, 2023 — Selution SLR, MedAlliance’s novel sirolimus-eluting balloon, has received conditional FDA…
Read More
Alameda, CA-based global healthcare company Penumbra has announced Food & Drug Administration (FDA) clearance and launch of Lightning Flash, which the company reports is the most advanced mechanical thrombectomy system on the market to address venous and pulmonary thrombus.
January 11, 2023
FDA Clearance and Launch Granted to Penumbra Mechanical Thrombectomy System
January 11, 2023 — The Alameda, Calif.-based global healthcare company Penumbra has announced U.S. Food & Drug…
Read More
Phase 2 trials underway with ninerafaxstat in three cardiovascular indications; multiple data read-outs expected in 2023
January 11, 2023
Imbria Enrolls First Patient in the Phase 2 IMPROVE-DiCE Clinical Trial Evaluating Ninerafaxstat in Patients with Heart Failure with Preserved Ejection Fraction
January 11, 2023 — Imbria Pharmaceuticals, Inc., a clinical stage, cardiometabolic company developing novel therapies…
Read More
Dean Kereiakes, MD, MSCAI
January 11, 2023
Shockwave Intravascular Lithotripsy-assisted TMVR Shows Promise for Patients with Severe Stenosis and Regurgitation
January 11, 2023 — In recent years, transcatheter mitral valve replacement (TMVR) treatment and technology has evolved…
Read More
A Rutgers analysis of U.S. stroke deaths from 1975 to 2019 has found both a dramatic decline and the potential for an important resurgence.
January 11, 2023
After 40 Years of Decline, Stroke Death Rates Are Rising Again
January 11, 2023 — A Rutgers analysis of U.S. stroke deaths from 1975 to 2019 has found both a dramatic decline and the…
Read More
CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under which AstraZeneca has agreed to acquire CinCor.
January 09, 2023
CinCor Pharma to be Acquired by AstraZeneca
January 9, 2023 — CinCor Pharma, Inc. announced that it has entered into a definitive agreement with AstraZeneca under…
Read More
Lara Barghout, President and Chief Executive Officer
January 09, 2023
ReCor Medical Names Lara Barghout President and Chief Executive Officer
January 9, 2023 — ReCor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announced the…
Read More
TGCV is an emerging cardiovascular disorder characterized by diffuse narrowing coronary atherosclerosis with triglyceride (TG) deposition caused by defective intracellular lipolysis. TGCV is an often-undiagnosed condition in patients who are resistant to standard therapies. Panels A and B concern two patients in their 60s with refractory angina pectoris and diabetes mellitus. After being diagnosed with TGCV, they started dietary intake of tricaprin. Their symptoms improved within a couple of months. Follow-
January 09, 2023
A Dietary Supplement Leads to Remarkable Regression in Atherosclerotic Lesions
January 9, 2023 — When we were little, our parents told us to take our vitamins so we could grow big and strong. Now,…
Read More
NIH-supported study finds no serious complications following rare immune condition, multisystem inflammatory syndrome (MIS-C)
January 06, 2023
COVID-19 Vaccine for Children After MIS-C Appears Safe
January 6, 2023 — A study of children and adolescents who received a COVID-19 vaccination following multisystem…
Read More
The ensemble delivery system of the Melody valve.
January 06, 2023
New Pediatric Investigation Article Reviews the Potential of Transcatheter Pulmonary Valve Replacement for Congenital Heart Disorders
January 6, 2023 — Patients with congenital heart diseases often suffer from obstructions in the right ventricular…
Read More
StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your practice’s coding, billing, and reimbursement operations.
January 05, 2023
A Look at the Changes in 2023 to Interventional Radiology/Cardiology CPT Codes
January 5, 2023 — StreamlineMD has provided updates for 2023 Radiology and IR CPT coding, which may impact your…
Read More
Mouaz Al-Mallah, MD, MSc, FASNC, 2023 ASNC President
January 05, 2023
Mouaz H. Al-Mallah, MD, MSc, FASNC, Installed as ASNC’s President for 2023
January 5, 2023 — Mouaz H. Al-Mallah, MD, MSc, FASNC, director of the cardiovascular PET program at the Houston…
Read More
This figure highlights 3 patients with a final diagnosis of low-grade uptake (Perugini grade-1). Endomyocardial biopsy results were available for the patient depicted in Panel B demonstrating ATTR-CA as the underlying pathology. Image created by Department of Nuclear Medicine, Medical University of Vienna, Austria.
January 05, 2023
Nuclear Medicine Bone Scan Study Identifies Prevalence and Outcomes of Cardiac Amyloidosis
January 5, 2023 — A new study has determined that approximately three percent of all bone scan patients have markers of…
Read More
Buffalo Bills safety Damar Hamlin, 24, collapsed in cardiac arrest during an NFL game with the Cincinnati Bengals on Monday night. Fortunately, the medical team was prepared and provided immediate CPR and defibrillation to restore his pulse.
January 04, 2023
Sudden Cardiac Arrest Foundation Urges Public Awareness and Action After Collapse of Damar Hamlin
January 4, 2023 — Millions watched as Buffalo Bills safety, Damar Hamlin, 24, collapsed in cardiac arrest during an NFL…
Read More
While playing in the Buffalo Bills - Cincinnati Bengals game on Monday Night Football on January 2, Bills player Damar Hamlin suffered cardiac arrest after a hit and was administered CPR on the field before being transferred to an area hospital, according to an overnight statement by the Buffalo Bills
January 04, 2023
AHA Issues Statement on Understanding Cardiac Arrest Following Damar Hamlin's Collapse During Monday Night Football
January 4, 2023 — While playing in the Buffalo Bills - Cincinnati Bengals game on Monday Night Football on January 2,…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now